Home > Insider Trading > Filing (0001567619-20-018886)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404281	Novus Therapeutics Inc.	NVUS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1792126	Logos Global Management Lp	1 Letterman Drive Ste. D3-700 San Francisco CA 94129		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-30	5,000	$24.03	150,000	No	4	P	Indirect	See Notes 1 and 2
Common Stock	Acquisiton	2020-10-30	31,000	$24.53	181,000	No	4	P	Indirect	See Notes 1 and 2
Common Stock	Acquisiton	2020-10-30	4,000	$25.97	185,000	No	4	P	Indirect	See Notes 1 and 2
Common Stock	Acquisiton	2020-10-30	15,000	$26.48	200,000	No	4	P	Indirect	See Notes 1 and 2
Common Stock	Disposition	2020-10-30	12,942	$26.64	187,058	No	4	S	Indirect	See Notes 1 and 2
Common Stock	Acquisiton	2020-10-30	12,942	$25.88	200,000	No	4	P	Indirect	See Notes 1 and 2
Common Stock	Disposition	2020-10-30	27	$27.02	199,973	No	4	S	Indirect	See Notes 1 and 2
Common Stock	Acquisiton	2020-10-30	15,000	$26.17	214,973	No	4	P	Indirect	See Notes 1 and 2
Common Stock	Acquisiton	2020-10-30	9,098	$25.55	224,071	No	4	P	Indirect	See Notes 1 and 2

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Notes 1 and 2
No	4	P	Indirect	See Notes 1 and 2
No	4	P	Indirect	See Notes 1 and 2
No	4	P	Indirect	See Notes 1 and 2
No	4	S	Indirect	See Notes 1 and 2
No	4	P	Indirect	See Notes 1 and 2
No	4	S	Indirect	See Notes 1 and 2
No	4	P	Indirect	See Notes 1 and 2
No	4	P	Indirect	See Notes 1 and 2

Footnotes

The reporting persons are Logos Global Management LP ("LGM"), Logos Global Master Fund LP (the "Fund"), and Logos GP LLC ("Fund GP"). LGM is the investment adviser of private funds, including the Fund. Fund GP is the general partner of the Fund. LGM is filing this report for itself and the other reporting persons. The reporting persons are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934.
The Fund holds the securities reported herein directly for the benefit of its investors. The securities may be deemed to be indirectly beneficially owned by LGM as investment adviser to the Fund and by Fund GP as general partner of the Fund. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.